Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

4 juin 2026 | Anna Bawden Health and social affairs correspondent
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant (…)
 Site référencé:  The Guardian (South&CentralAsia)

The Guardian (South&CentralAsia) 

NBA finals 2026 Game 1 : New York Knicks v San Antonio Spurs – live
4/06/2026
Middle East crisis live : Israel and Lebanon agree to renew ceasefire ; US House rebukes Trump over Iran war
4/06/2026
Ukraine war briefing : Russia losing on the ground so pivots to air war, say analysts
4/06/2026
Japan sees shortage of plastic bags, trays and gloves, as Iran war-induced naphtha shortage worsens
4/06/2026
‘Every year I get new pictures’ : the fight to preserve the memory of Tiananmen
4/06/2026
Savage House review – Claire Foy and Richard E Grant sell it hard in bewigged 18th-century caper
4/06/2026